Close this search box.
Jeff Berkowitz, CEO & Director of Real Endpoints

Jeff Berkowitz, CEO & Director of Real Endpoints

Jeff Berkowitz’s perspective has been shaped by a career spanning most key verticals in healthcare and the drug supply chain with executive committee and other senior roles at UnitedHealth Group, Walgreens Boots Alliance and Merck. Jeff, a lawyer by training, is a recognized expert and thought leader in market access and reimbursement for pharmaceuticals and serves on the Board of Directors of a number of publicly traded pharmaceutical companies including Lundbeck A/S, Esperion Therapeutics, and Zealand Pharmaceuticals, and is also on the board of the drug distributor Uniphar.

Jeff is currently the CEO of Real Endpoints, a leader in providing insights, support and tools to strengthen access to pharmaceutical innovation for an evolving healthcare landscape with a concentrated focus on value-based arrangements, patient services and access and pricing support for manufacturers and payers.

we are here for you

For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.

Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.